Drug Profile
RAD 100
Alternative Names: RAD100Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Futura Medical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Anaesthesia
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Anaesthesia in United Kingdom (Topical, Gel)
- 19 Mar 2012 Optimisation trials are ongoing in United Kingdom
- 03 Feb 2011 RAD 100 is still available for licensing as of 03 Feb 2011. http://www.futuramedical.co.uk